Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aes-103 for Hypoxia-Mediated Exercise Performance Decrements
NCT01871142Phase 2Completed
- Sponsor
- Colorado State University
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of 5-hydroxymethylfurfural in acute mountain sickness (AMS), sponsored by Colorado State University. Primary endpoint: Endurance Exercise Performance (Time Trial). Started Mar 2013; status: completed.
02
Drugs
5-hydroxymethylfurfural
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT01871142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871142.